Results of Operations
We have neither engaged in any operations nor generated any operational revenues to date. Our only activities for the nine months ended September 30, 2021 and for the period from July 6, 2020 (inception) through September 30, 2020 were organizational activities, those necessary to prepare for the initial public offering, described below, and, after our initial public offering, identifying a target company for a business combination. We do not expect to generate any operating revenues until after the completion of our initial business combination. We generate non-operating income in the form of interest income on cash and cash equivalents held after the initial public offering. In addition, the Company will recognize non-operating income or loss on the change in fair of warrant liabilities. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended September 30, 2021, we had net income of $2,995,085, which resulted from by the change in fair value of warrant liabilities of $3,241,000 and an unrealized gain on marketable securities held in Trust Account in the amount of $43,200, which was partially offset by operating and formation costs of $262,487, and franchise tax expense of $26,628.
For the nine months ended September 30, 2021, we had net income of $12,290,535, which resulted from the change in fair value of warrant liabilities of $17,611,084, and an unrealized gain on marketable securities held in Trust Account in the amount of $48,981, which was partially offset by an excess of private placement warrant fair value over purchase price of $3,507,000, warrant issuance costs of $966,646 associated with the Initial Public Offering, operating and formation costs of $780,815, and franchise tax expense of $115,069.
For the period from July 6, 2020 (inception) through September 30, 2020, we had net income of $0.
Liquidity and Capital Resources
As of September 30, 2021, December 31, 2020, and September 30, 2020, the Company had $294,918, $1,594, and $250 in cash held outside of the Trust Account, respectively, and a working capital balance of $605,249, and working capital deficits of $120,906, and $117,250 respectively.
The Company’s liquidity needs prior to the consummation of the Initial Public Offering were satisfied through the proceeds of $25,000 from the sale of the Founder Shares, and a loan of up to $300,000 under an unsecured and non-interest bearing promissory note. Subsequent to the consummation of the Initial Public Offering, the Company’s liquidity will be satisfied through the net proceeds from the private placement held outside of the Trust Account.
In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated to, loan us funds as may be required (“Working Capital Loans”). As of September 30, 2021, there were no amounts outstanding under any Working Capital Loan.
For the nine months ended September 30, 2021, net cash used in operating activities was $1,206,215, which was due to the change in fair value of warrants of $17,611,084, changes in operating assets and liabilities of $310,331, and net gain on investments in the Trust Account of $48,981, partially offset by our net income of $12,290,535, excess of private placement warrants fair value over purchase price in the amount of $3,507,000 and expensed offering costs of $966,646.
For the nine months ended September 30, 2021, net cash used in investing activities was $317,500,000, which was due to the amount of net proceeds from the initial public offering being deposited to the Trust Account.
For the nine months ended September 30, 2021, net cash provided by financing activities was $318,999,539, which was comprised of $311,150,000 in proceeds from the issuance of units in the initial public offering net of underwriter’s discount paid, $8,350,000 in proceeds from the issuance of warrants in a private placement to our Sponsor, and proceeds from issuance of Sponsor Note of $41,500, offset in part by payment of $377,961 for offering costs associated with the initial public offering and repayment of the outstanding balance on the promissory note to our Sponsor of $164,000.
For the period from July 6, 2020 (inception) through September 30, 2020, net cash provided by financing activities was $250, which was comprised of $117,500 in proceeds from issuance of Sponsor Note, and $25,000 in proceeds from sale of Class B common stock to Sponsor, which was offset by payment of offering costs in the amount of $142,250.
We have incurred and expect to continue to incur significant costs in pursuit of our acquisition plans. We may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to complete our business combination or because we become obligated to redeem a significant number of public shares upon completion of our business combination, in which case we may issue additional securities or incur debt in connection with such business combination.
23